Replication Study in Chinese Population and Meta-Analysis Supports Association of the 5p15.33 Locus with Lung Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ke, Juntao ^a   Zhong, Rong ^a   Zhang, Ti ^a   Liu, Lifeng ^a   Rui, Rui ^a   Shen, Na ^a   Sun, Yu ^a   Liu, Li ^b   Cheng, Liming ^a   Miao, Xiao Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CHROMOSOME 5P; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, GENETIC; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84876983442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062485     Document Type: Article

References (41)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians 61: 69-90.
2. Zhang H, Cai B, (2003) The impact of tobacco on lung health in China. Respirology 8: 17-21.
3. Chen WQ, (2009) [Estimation of cancer incidence and mortality in China in 2004-2005]. Zhonghua Zhong Liu Za Zhi 31: 664-668.
4. Lichtenstein P HN, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000 (3432) (): 78-85.
5. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40: 1407-1409.
6. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
7. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics 40: 616-622.
8. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
9. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nature Genetics 40: 1404-1406.
10. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, et al. (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 69: 6633-6641.
11. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679-691.
12. Hu Z, Wu C, Shi Y, Guo H, Zhao X, et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nature Genetics 43: 792-796.
13. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y, (2001) A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with Apoptosis. Biochemical and Biophysical Research Communications 280: 1148-1154.
14. Kohno T, Kunitoh H, Shimada Y, Shiraishi K, Ishii Y, et al. (2010) Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis 31: 834-841.
15. Miki D, Kubo M, Takahashi A, Yoon K-A, Kim J, et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nature Genetics 42: 893-896.
16. Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, et al. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30: 1368-1371.
17. Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, et al. (2011) Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis 32: 1493-1499.
18. Bae EY, Lee SY, Kang BK, Lee EJ, Choi YY, et al. (2012) Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 17: 699-706.
19. Chen XF, Cai S, Chen QG, Ni ZH, Tang JH, et al. (2012) Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genetics and Molecular Research 11: 370-378.
20. Zhong H, Prentice RL (2009) Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Genetic Epidemiology: n/a-n/a.
21. Pabalan NA, (2010) Meta-analysis in cancer genetics. Asian Pac J Cancer Prev 11: 33-38.
22. Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, et al. (2012) Telomerase Reverse Transcriptase Locus Polymorphisms and Cancer Risk: A Field Synopsis and Meta-Analysis. JNCI Journal of the National Cancer Institute 104: 840-854.
23. Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, et al. (2012) Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Human Molecular Genetics 21: 4980-4995.
24. Crawford DC, Yin J, Li Y, Yin M, Sun J, et al. (2012) TERT-CLPTM1L Polymorphism rs401681 Contributes to Cancers Risk: Evidence from a Meta-Analysis Based on 29 Publications. PLoS ONE 7: e50650.
25. Thakkinstian A, (2005) Systematic Review and Meta-Analysis of the Association between 2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review. American Journal of Epidemiology 162: 201-211.
26. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
27. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
28. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
29. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J, (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306.
30. Mullen B, Muellerleile P, Bryant B, (2001) Cumulative Meta-Analysis: A Consideration of Indicators of Sufficiency and Stability. Personality and Social Psychology Bulletin 27: 1450-1462.
31. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
32. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nature Genetics 41: 221-227.
33. Yoon KA, Park JH, Han J, Park S, Lee GK, et al. (2010) A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Human Molecular Genetics 19: 4948-4954.
34. Yoshiura K, Machida J, Daack-Hirsch S, Patil SR, Ashworth LK, et al. (1998) Characterization of a novel gene disrupted by a balanced chromosomal translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate. Genomics 54: 231-240.
35. Colombo J, De Freitas FA, Calmon M, Cury PM, Fukuyama EE, et al. (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncology Reports 21: 649-663.
36. Asakura T, Imai A, Ohkubo-Uraoka N, Kuroda M, Iidaka Y, et al. (2005) Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Oncol Rep 14: 601-607.
37. Deb SP, James MA, Wen W, Wang Y, Byers LA, et al. (2012) Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus. PLoS ONE 7: e36116.
38. Baird DM (2010) Variation at the TERT locus and predisposition for cancer. Expert Reviews in Molecular Medicine 12.
39. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17: 498-502.
40. Greider CW, Blackburn EH, (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413.
41. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.